Skip to main content

Closed

IBRX: ImmunityBio, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-185.4%

ROIC-44.5%

Financially safe

Stretched

Debt / equity-1.29×

Interest coverage-2.3×

Current ratio6.67×

ImmunityBio, Inc.

IBRXNASDAQ Global Select·USD·Closed

ImmunityBio, Inc.

IBRXNASDAQ·USD·Closed

$7.17

−3.76%

$7.17

−$0.28 (3.76%)

52W Range

50thpctl

Volume

0.73×avg

Mkt Cap

7.51BUSD

P/E

-8.4TTM

Div Yield

–ann

52W Range

50thpctl

Volume

0.73×avg

Market Cap

7.51BUSD

P/E Ratio

-8.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings